Pfizer exploring sale of hospital drugs unit, Reuters reports

Pfizer (PFE) is exploring the sale of its hospital drugs unit, now called Pfizer Hospital, which was formed after Pfizer bought Hospira for about $17B in 2015, three people familiar with the matter told Reuters’ Anirban Sen. The pharma giant has hired Goldman Sachs (GS) to gauge initial interest from potential buyers, which include private equity firms and other pharmaceutical companies, as the drugmaker, under pressure from activist investor Starboard Value, looks to divest non-core assets, the report noted.